Date: Feb 11, 2013 Source: Business Wire (
click here to go to the source)
LENEXA, Kan.--(BUSINESS WIRE)--Evogen gains depth and expertise with the addition of two new executives.. The industry veterans will position Evogen as a provider of point-of care diagnostics for infectious disease and reinvigorate Sceptor Industries as a leader of sensitive sample collection for government and private sector needs.
The newest members to the executive team are well-known industry leaders:
Hans Kastensmith, President & CEO, comes to Evogen with 23 years of progressive achievements in healthcare. Mr. Kastensmith founded, managed, established financing for and advised a number of healthcare technology and population health management companies. Mr. Kastensmith has significant experience in running both private and public healthcare enterprises and led three corporate acquisitions for a public company. In addition, Mr. Kastensmith maintains vast global networks of high profile relationships in the healthcare/diagnostics industry and government entities and serves as Chairman of several Boards.
Robert Dondes, Chief Operating Officer, is an accomplished executive with c-suite experience in private and publicly traded healthcare companies. With a proven record of exceeding corporate financial and operational objectives, Mr. Dondes also sits on the board of a major medical device company. Mr. Dondes brings in-depth knowledge of the investment business, having worked as a senior advisor with several private equity and venture capital management companies. Further, Mr. Dondes' tenure as a managed care CEO brings insight that will serve Evogen well in the current climate of accountable care organizations and healthcare reform.
About Evogen, Inc.
Evogen meets the molecular diagnostic collection and detection needs of a diverse range of customers. The Evogen portfolio includes DNA extraction methodologies, air collection and monitoring and proprietary PCR probe technology providing reliable, sensitive and specific answers. Through analysis of the specific needs of each customer, Evogen delivers systems and solutions that provide rapid results while lessening laboratory workflow impact. Visit Evogen.com
About Sceptor Industries, Inc.
Sceptor provides advanced biological system platforms, assays and reagent kits, and services to detect and identify biological threat agents. These detection and identification systems are used by the Federal Government and major systems integrators within the biodefense industries for a range of specialist applications including building security, civil defense, and military force protection. These biodetection systems are distinguished from competition by their superior performance, stability, ease of use, and affordability.
Contacts
Evogen/Sceptor
Rich St.Clair, 913-948-5643
Vice President, Marketing & Business Development
Rstclair@evogen.com
